Neuroceuticals key facts
as of Oct 2026- Developer of a medical device incubator and accelerator intended to support and advance medical start-up companies.
- Neuroceuticals is valued at approximately $13.1M as of Oct 2026 (last reported valuation).
- It has raised $4.6M.
- Notable investors include Mizuho Capital, Sasaki Food, Astem, Kaga Electronics, Kyushu University — 8 tracked in total.
- Status: Privately Held (backing).
Neuroceuticals's last reported valuation, Nov 2018. Nothing priced has surfaced since.
- ·Watch Neuroceuticals: the Monday email on marks, rounds and moves
Neuroceuticals funding rounds
No funding rounds for Neuroceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Neuroceuticals
8Neuroceuticals valuation
Neuroceuticals's last reported valuation was $13.1 million in Nov 2018. No priced round, secondary trade or fund mark has surfaced since.
Neuroceuticals investors
8 investors are on record for Neuroceuticals, including Mizuho Capital, Sasaki Food, Astem and Kaga Electronics.
About Neuroceuticals
Developer of a medical device incubator and accelerator intended to support and advance medical start-up companies. The company offers mentorship, funding support, and access to research and clinical expertise, enabling medical start-ups to develop and commercialize innovative healthcare technologies efficiently.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2009
- Employees
- 30
- Website
- nci-md.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.